Medico Remedies
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Medico Remedies said credit rating agency CRISIL has reviewed its bank facilities ratings and reaffirmed the long-term rating at CRISIL BBB- with a stable outlook, along with a CRISIL A3 short-term rating. The total rated facilities were raised to ₹42 crore, up from ₹19 crore previously, reflecting an enhancement of ₹23 crore. The facilities, all from Kotak Mahindra Bank, comprise a term loan, packing credit and a letter of credit. The ratings are valid until March 2027 and remain under continuous surveillance. Medico Remedies, a pharmaceutical formulation manufacturer, had reported revenue of ₹206.38 crore for the fiscal year ended March 2026, with exports making up the bulk of sales.
Powered by Tijori
Medico Remedies said credit rating agency CRISIL has reviewed its bank facilities ratings and reaffirmed the long-term rating at CRISIL BBB- with a stable outlook, along with a CRISIL A3 short-term rating. The total rated facilities were raised to ₹42 crore, up from ₹19 crore previously, reflecting an enhancement of ₹23 crore. The facilities, all from Kotak Mahindra Bank, comprise a term loan, packing credit and a letter of credit. The ratings are valid until March 2027 and remain under continuous surveillance. Medico Remedies, a pharmaceutical formulation manufacturer, had reported revenue of ₹206.38 crore for the fiscal year ended March 2026, with exports making up the bulk of sales.
Powered by Tijori
Jan 27 (Reuters) - Medico Remedies Ltd MEDC.NS:
SECURES ORDER FOR 371.8 MILLION RUPEES
Source text: ID:nBSEhsJrF
Further company coverage: MEDC.NS
(([email protected];))
Jan 27 (Reuters) - Medico Remedies Ltd MEDC.NS:
SECURES ORDER FOR 371.8 MILLION RUPEES
Source text: ID:nBSEhsJrF
Further company coverage: MEDC.NS
(([email protected];))
Jan 20 (Reuters) - Medico Remedies Ltd MEDC.NS:
SECURED GOVERNMENT SUPPLY ORDER FOR 732.3 MILLION RUPEES
Source text: ID:nBSE56tNBp
Further company coverage: MEDC.NS
(([email protected];))
Jan 20 (Reuters) - Medico Remedies Ltd MEDC.NS:
SECURED GOVERNMENT SUPPLY ORDER FOR 732.3 MILLION RUPEES
Source text: ID:nBSE56tNBp
Further company coverage: MEDC.NS
(([email protected];))
April 8 (Reuters) - Medico Remedies Ltd MEDC.NS:
MEDICO REMEDIES LTD - SECURES $1.9 MILLION SUPPLY ORDER FROM DOMINICAN REPUBLIC
MEDICO REMEDIES LTD - TO SUPPLY TABLETS, CAPSULES, DRY SYRUPS WITHIN 3 MONTHS
Source text: ID:nBSE7XwGKc
Further company coverage: MEDC.NS
(([email protected];;))
April 8 (Reuters) - Medico Remedies Ltd MEDC.NS:
MEDICO REMEDIES LTD - SECURES $1.9 MILLION SUPPLY ORDER FROM DOMINICAN REPUBLIC
MEDICO REMEDIES LTD - TO SUPPLY TABLETS, CAPSULES, DRY SYRUPS WITHIN 3 MONTHS
Source text: ID:nBSE7XwGKc
Further company coverage: MEDC.NS
(([email protected];;))
Aug 13 (Reuters) - Medico Remedies Ltd MEDC.NS:
GOT NOTICE FOR DEMAND OF TAX TO PAY GST WORTH 29.4 MILLION RUPEES
Further company coverage: MEDC.NS
(([email protected];))
Aug 13 (Reuters) - Medico Remedies Ltd MEDC.NS:
GOT NOTICE FOR DEMAND OF TAX TO PAY GST WORTH 29.4 MILLION RUPEES
Further company coverage: MEDC.NS
(([email protected];))
July 20 (Reuters) - Medico Remedies Ltd MEDC.NS:
RE-APPOINTS HARESH MEHTA AS CHAIRMAN
Source text for Eikon: ID:nBSE6ZpYcR
Further company coverage: MEDC.NS
(([email protected];))
July 20 (Reuters) - Medico Remedies Ltd MEDC.NS:
RE-APPOINTS HARESH MEHTA AS CHAIRMAN
Source text for Eikon: ID:nBSE6ZpYcR
Further company coverage: MEDC.NS
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Medico Remedies do?
Medico Remedies Private Limited is a prominent manufacturer and exporter of pharmaceutical formulations, specializing in a wide range of therapeutic categories such as antidiabetics, antihypertensives, antiretrovirals, and more.
Who are the competitors of Medico Remedies?
Medico Remedies major competitors are Medicamen Biotech, Trident Lifeline, Shivalik Rasayan, Lyka Labs, Albert David, Ambalal Sarabhai Ent, Gennex Laboratories. Market Cap of Medico Remedies is ₹322 Crs. While the median market cap of its peers are ₹311 Crs.
Is Medico Remedies financially stable compared to its competitors?
Medico Remedies seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Medico Remedies pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Medico Remedies latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Medico Remedies allocated its funds?
Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable
How strong is Medico Remedies balance sheet?
Balance sheet of Medico Remedies is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Medico Remedies improving?
Yes, profit is increasing. The profit of Medico Remedies is ₹13.12 Crs for TTM, ₹10.09 Crs for Mar 2025 and ₹8.29 Crs for Mar 2024.
Is the debt of Medico Remedies increasing or decreasing?
Yes, The net debt of Medico Remedies is increasing. Latest net debt of Medico Remedies is ₹16.93 Crs as of Mar-26. This is greater than Mar-25 when it was ₹11.79 Crs.
Is Medico Remedies stock expensive?
Medico Remedies is not expensive. Latest PE of Medico Remedies is 24.55, while 3 year average PE is 59.84. Also latest EV/EBITDA of Medico Remedies is 19.9 while 3yr average is 43.89.
Has the share price of Medico Remedies grown faster than its competition?
Medico Remedies has given lower returns compared to its competitors. Medico Remedies has grown at ~-18.91% over the last 3yrs while peers have grown at a median rate of 2.7%
Is the promoter bullish about Medico Remedies?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Medico Remedies is 61.38% and last quarter promoter holding is 61.38%.
Are mutual funds buying/selling Medico Remedies?
There is Insufficient data to gauge this.